Liftstream is an executive search recruitment company in the life sciences sector
Women Executives: Stepping Up to the C-suite and Board (Event Schedule)
Event Date:
Thursday, December 3, 2015 from 4:00 PM to 7:30 PM (EST)
Event Location:
Biogen, Bio-9 Building, 300 Binney Street Cambridge, MA 02142 – View Map
Posted in Board Director Appointments, Corporate Governance, Workplace Diversity
Tagged #BoardStep, Alnylan Pharmaceuticals, Atlas Venture, biogen, board director, Broad Institute, Bruce Booth, celgene, CEO, Gwen Acton, Ironwood, J&J Innovation, Jodie Morrison, Karl Simpson, Luc Therapeutics, Marian Nakada, Marsha Fanucci, Mary Thistle, Michael Bonney, Nimbus Therapeutics, Paula Ragan, Pauline Jen Ryan, Professor Susan Adams, Rosana Kapeller, Samantha Singer, Susan Alexander, Tokai, Tokai Pharmaceuticals, Vanessa King, X4 Pharmaceuticals
Leave a comment
Women Currently only 10% of Biotech Boards, Gender Study Shows
Authored by Karl Simpson
Posted in Executive Appointments, Pharmaceutical business, Recruitment Market
Tagged Bay Area Cluster, biotechnology, Board DIrectors, Boston, Boston Biotech, California, corporate VC, Diversity, europe, executive search, female, Gender, Karl Simpson, leadership, life sciences, Liftstream, male, Massachusetts, non executive directors, NVCA, report, UK, USA, venture capital
Leave a comment
13 Life Science Leaders to watch in 2013 – The Verdict!
Authored by Liftstream
Posted in Pharmaceutical business
Tagged 13 for 13, AstraZeneca, Dalvir Gill, EFPIA, Flemming Ornskov, Foundation Medicine, Francois Nader, Gilead Sciences, James Sheppard, Jeff Leiden, Jeremy Levin, John Martin, Jorn Aldag, Karl Simpson, Karl-Ludwig Kley, Liftstream, Merck KGaA, Michael Pellini, NPS Pharmaceuticals, Pascal Soriot, Richard Bergstom, Shire, Teva, TransCelerate, uniQure, Vertex Pharmaceuticals
Leave a comment
Dr Jeremy Levin – Teva – Executive Leadership Series
Authored by Karl Simpson
Posted in Pharmaceutical business
Tagged 13for13, Board of Directors, Jeremy Levin, Karl Simpson, Liftstream, Teva
Leave a comment
Open Innovation could spur diversity
Authored by Karl Simpson
Posted in General, Pharmaceutical business, Workplace Diversity
Tagged Berkeley, biomarkers, biotechnology, business, china, Diversity, Finland, Haas Business School, Henry Chesbrough, innovation, innovation black hole, Karl Simpson, manufacturing, medicine, Open Innovation, pharmaceutical executive, pharmaceuticals, R&D, research, research and development, South America, University of California
Leave a comment
Liftstream Life Science Newsletter August Edition
The August edition of the newsletter contains
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business, Recruitment Market
Tagged Audentes Therapeutics, august, big pharma, biotechnology, bioValley, CEO, Cluster, Duchenne Muscular Dystrophy, Inflection bioscience, Ipsen, Karl Simpson, Liftstream, Liftstream Newsletter, managing conflict, Michael O'Neill, pharmaceutical, start up, Syntaxin, venture capital, venturing financing
1 Comment